126 related articles for article (PubMed ID: 12234110)
1. The assessment of myocardial viability: a review of current diagnostic imaging approaches.
Thornhill RE; Prato FS; Wisenberg G
J Cardiovasc Magn Reson; 2002; 4(3):381-410. PubMed ID: 12234110
[TBL] [Abstract][Full Text] [Related]
2. Is viability still viable after the STICH trial?
Cortigiani L; Bigi R; Sicari R
Eur Heart J Cardiovasc Imaging; 2012 Mar; 13(3):219-26. PubMed ID: 22080451
[TBL] [Abstract][Full Text] [Related]
3. [Reversible dysfunction of the left ventricle in coronary disease (part two): hibernation and methods for detection of viability].
Vlahović A; Popović A
Med Pregl; 2000; 53(3-4):146-53. PubMed ID: 10965679
[TBL] [Abstract][Full Text] [Related]
4. Ischemically compromised myocardium displays different time-courses of functional recovery: correlation with morphological alterations?
Haas F; Jennen L; Heinzmann U; Augustin N; Wottke M; Schwaiger M; Lange R
Eur J Cardiothorac Surg; 2001 Aug; 20(2):290-8. PubMed ID: 11463546
[TBL] [Abstract][Full Text] [Related]
5. Myocardial viability in ischemic heart disease: new directions and perspectives.
Previtali M
Ital Heart J; 2001 Feb; 2(2):93-9. PubMed ID: 11256549
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability.
Kwong RY; Korlakunta H
Top Magn Reson Imaging; 2008 Feb; 19(1):15-24. PubMed ID: 18690157
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction.
Williams MJ; Odabashian J; Lauer MS; Thomas JD; Marwick TH
J Am Coll Cardiol; 1996 Jan; 27(1):132-9. PubMed ID: 8522686
[TBL] [Abstract][Full Text] [Related]
8. Assessment of myocardial viability in chronic ischemic heart disease: current status.
Rizzello V; Poldermans D; Bax JJ
Q J Nucl Med Mol Imaging; 2005 Mar; 49(1):81-96. PubMed ID: 15724138
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability.
Meluzín J; Cerný J; Spinarová L; Toman J; Groch L; Stetka F; Frélich M; Hude P; Krejcí J; Rambousková L; Panovský R
Eur J Heart Fail; 2003 Jan; 5(1):85-93. PubMed ID: 12559220
[TBL] [Abstract][Full Text] [Related]
10. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
[TBL] [Abstract][Full Text] [Related]
11. Rest-injected 201thallium in the evaluation of myocardial viability.
Perrone-Filardi P; Dellegrottaglie S; Chiariello M
Cardiologia; 1999 Jun; 44(6):515-20. PubMed ID: 10443052
[TBL] [Abstract][Full Text] [Related]
12. Assessment of myocardial viability with cardiac magnetic resonance imaging.
Ozben B; Cinçin AA; Mutlu B
Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():71-6. PubMed ID: 19028638
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of hibernating myocardium in ischemic left ventricular dysfunction.
Schinkel AF; Bax JJ; Delgado V; Poldermans D; Rahimtoola SH
Am J Med; 2010 Nov; 123(11):978-86. PubMed ID: 21035587
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy.
Gerber BL; Rousseau MF; Ahn SA; le Polain de Waroux JB; Pouleur AC; Phlips T; Vancraeynest D; Pasquet A; Vanoverschelde JL
J Am Coll Cardiol; 2012 Feb; 59(9):825-35. PubMed ID: 22361403
[TBL] [Abstract][Full Text] [Related]
15. Nuclear imaging techniques for the assessment of myocardial viability.
Jain D; Zaret BL
Cardiol Clin; 1995 Feb; 13(1):43-57. PubMed ID: 7796431
[TBL] [Abstract][Full Text] [Related]
16. Myocardial viability: magnetic resonance assessment of functional reserve and tissue characterization.
Watzinger N; Saeed M; Wendland MF; Akbari H; Lund G; Higgins CB
J Cardiovasc Magn Reson; 2001; 3(3):195-208. PubMed ID: 11816616
[TBL] [Abstract][Full Text] [Related]
17. MRI assessment of myocardial viability: comparison with other imaging techniques.
Baer FM; Theissen P; Schneider CA; Kettering K; Voth E; Sechtem U; Schicha H
Rays; 1999; 24(1):96-108. PubMed ID: 10358387
[TBL] [Abstract][Full Text] [Related]
18. Assessment of myocardial viability with dobutamine stress echocardiography in patients with ischemic left ventricular dysfunction.
Yao SS; Chaudhry FA
Echocardiography; 2005 Jan; 22(1):71-83. PubMed ID: 15660693
[TBL] [Abstract][Full Text] [Related]
19. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.
Ling LF; Marwick TH; Flores DR; Jaber WA; Brunken RC; Cerqueira MD; Hachamovitch R
Circ Cardiovasc Imaging; 2013 May; 6(3):363-72. PubMed ID: 23595888
[TBL] [Abstract][Full Text] [Related]
20. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis.
Bax JJ; Schinkel AF; Boersma E; Elhendy A; Rizzello V; Maat A; Roelandt JR; van der Wall EE; Poldermans D
Circulation; 2004 Sep; 110(11 Suppl 1):II18-22. PubMed ID: 15364832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
